BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Li HC, Lo SY. Hepatitis C virus: Virology, diagnosis and treatment. World J Hepatol 2015; 7(10): 1377-1389 [PMID: 26052383 DOI: 10.4254/wjh.v7.i10.1377]
URL: https://www.wjgnet.com/1948-5182/full/v7/i10/1377.htm
Number Citing Articles
1
T.B. Salas-Villalobos, S.A. Lozano-Sepúlveda, A.R. Rincón-Sánchez, M. Govea-Salas, A.M. Rivas-Estilla. Mechanisms involved in liver damage resolution after hepatitis C virus clearanceMedicina Universitaria 2017; 19(75) doi: 10.1016/j.rmu.2017.05.005
2
Constant Assi, Amadou Ouattara, Siaka Kone, Dramane Soro, Emile Allah-Kouadio, Claude Ghislain Kouakou, Nigué Luc, Benoît-Mathieu Camara, Marie-Jeanne Lohoues-Kouacou. Screening for Hepatitis B and C in Occupational Settings: Cross-Sectional Study about 4268 Corporates Agents in Côte d’IvoireOpen Journal of Gastroenterology 2017; 7(03) doi: 10.4236/ojgas.2017.73010
3
S. P. Rajasekar, M. Pitchaimani, Quanxin Zhu. Probing a Stochastic Epidemic Hepatitis C Virus Model with a Chronically Infected Treated PopulationActa Mathematica Scientia 2022; 42(5) doi: 10.1007/s10473-022-0521-1
4
Amany Belal, Aly Abdou, Samar F. Miski, Mohamed A. M. Ali, Heba I. Ghamry, Ahmad J. Obaidullah, Mohamed Y. Zaky, Ahmed H. E. Hassan, Eun Joo Roh, Ahmed A. Al-Karmalawy, Mona H. Ibrahim. Exploring the potential of some natural indoles as antiviral agents: quantum chemical analysis, inverse molecular docking, and affinity calculationsFrontiers in Chemistry 2025; 12 doi: 10.3389/fchem.2024.1521298
5
Laiba Masood, Nayyer Islam, Muhammad Irfan, Ameer Fawad Zahoor, Haroon Khalid Syed, Muhammad Shahid Shah, Muhammad Ajmal Shah, Muhammad Ali Syed, Sana Hanif. Infectious Diseases Drug Delivery Systems2023;  doi: 10.1007/978-3-031-20521-7_15
6
William David Green, Erik A. Karlsson, Melinda A. Beck. Nutrition and Infectious Diseases2021;  doi: 10.1007/978-3-030-56913-6_5
7
Xing-Yue Ji, Jin-Hua Chen, Guang-Hui Zheng, Meng-Hao Huang, Lei Zhang, Hong Yi, Jie Jin, Jian-Dong Jiang, Zong-Gen Peng, Zhuo-Rong Li. Design and Synthesis of Cajanine Analogues against Hepatitis C Virus through Down-Regulating Host Chondroitin Sulfate N-Acetylgalactosaminyltransferase 1Journal of Medicinal Chemistry 2016; 59(22) doi: 10.1021/acs.jmedchem.6b01301
8
Naiema K. Ali, Ragaa R. Mohamed, Bothina E. Saleh, Manal M. Alkady, Eman S. Farag. Occult hepatitis C virus infection among haemodialysis patientsArab Journal of Gastroenterology 2018; 19(3) doi: 10.1016/j.ajg.2018.09.001
9
Lorraine Matandirotya, Lauren Burke, Ella Dimascio, Sarah Menezes, Katie Allott, Adrian Whitehouse, Blossom Damania. The dynamic interplay between viruses and host non-coding RNA speciesFEMS Microbiology Reviews 2026; 50 doi: 10.1093/femsre/fuag003
10
Patrycja Sroga, David Safronetz, Derek R Stein. Nanobodies: A New Approach for the Diagnosis and Treatment of Viral Infectious DiseasesFuture Virology 2020; 15(3) doi: 10.2217/fvl-2019-0167
11
Ebada Mohamed Said, Badawy A. Abdulaziz, Mohamed El Kassas, Ibrahim Hussein El Attar, Mohammed Emadeldeen, Sherief M. Abd-Elsalam. RETRACTED ARTICLE: High success rates for the use of sofosbuvir/ombitasvir/paritaprevir/ritonavir + ribavirin and sofosbuvir/simeprevir/daclatasvir + ribavirin in retreatment of chronic hepatitis C infection after unsuccessful sofosbuvir/daclatasvir therapy: a real-life experienceArchives of Virology 2020; 165(7) doi: 10.1007/s00705-020-04639-x
12
Chee-Hing Yang, Hui-Chun Li, Tzu-Shan Ku, Pi-Ching Wu, Yung-Ju Yeh, Ju-Chien Cheng, Teng-Yi Lin, Shih-Yen Lo. Hepatitis C virus down-regulates SERPINE1/PAI-1 expression to facilitate its replicationJournal of General Virology 2017; 98(9) doi: 10.1099/jgv.0.000901
13
Berin Karaman Mayack, Muhammed Moyasar Alayoubi, Hakan Mikail Gezginci. In silico design of potential HCV NS5B inhibitors: a comprehensive approach combining combinatorial library generation, ensemble docking, MM-GBSA calculations, QSAR model development, and molecular dynamicsJournal of Research in Pharmacy 2025; 29(2) doi: 10.12991/jrespharm.1634330
14
Matthew Lloyd, Christopher W. Farnsworth. The Opioid Epidemic: Associated Infections and Diagnostic MethodsClinical Microbiology Newsletter 2020; 42(18) doi: 10.1016/j.clinmicnews.2020.08.003
15
Zhijiang Miao, Zhenrong Xie, Jing Miao, Jieyu Ran, Yue Feng, Xueshan Xia. Regulated Entry of Hepatitis C Virus into HepatocytesViruses 2017; 9(5) doi: 10.3390/v9050100
16
Surendra Kumar Shukla, Vijay Kumar. Dietary Interventions in Liver Disease2019;  doi: 10.1016/B978-0-12-814466-4.00006-9
17
Nastaran Rezaee, Laleh Babaeekhou, Maryam Ghane. Hepatitis C virus in Iran; transmission routes, growth in 3a genotype distribution, and lack of liver marker relation with genotypesJournal of Research in Medical Sciences 2020; 25(1) doi: 10.4103/jrms.JRMS_482_19
18
Sumeet Singh, Manjusha Pal, Samita Verma, Mukesh Samant. Cytokine Response Against Major Human Viral Infections2025;  doi: 10.1016/B978-0-443-15283-2.00011-7
19
Davit Baliashvili, Henry M. Blumberg, Neel R. Gandhi, Francisco Averhoff, David Benkeser, Shaun Shadaker, Lia Gvinjilia, Aleksandre Turdziladze, Nestani Tukvadze, Mamuka Chincharauli, Maia Butsashvili, Lali Sharvadze, Tengiz Tsertsvadze, Jaba Zarkua, Russell R. Kempker. Hepatitis C care cascade among patients with and without tuberculosis: Nationwide observational cohort study in the country of Georgia, 2015–2020PLOS Medicine 2023; 20(5) doi: 10.1371/journal.pmed.1004121
20
Wasun Chantratita, Keum-Soo Song, Choi GunHo, Viroj Pongthanapisith, Nipa Thongbaiphet, Garanyuta Wongtabtim, Ekawat Pasomsub, Kanokwan Angkanavin, Satish Balasaheb Nimse, Mukesh Digambar Sonawane, Shrikant Dasharath Warkad, Taisun Kim. 6 HCV genotyping 9G test and its comparison with VERSANT HCV genotype 2.0 assay (LiPA) for the hepatitis C virus genotypingJournal of Virological Methods 2017; 239 doi: 10.1016/j.jviromet.2016.10.009
21
Wai-Chiu Tsoi, Catriona Simpson, Lisa Jarvis, Alan Smith, Ninette Robbins, Ramune Sepetiene, Sonu Bhatnagar. Multicenter evaluation of the new Alinity s anti-HCV II assay for routine hepatitis C virus blood screeningJournal of Clinical Virology Plus 2023; 3(1) doi: 10.1016/j.jcvp.2023.100136
22
Kefayatullah Nazary, Sana Anwar, Ankita Y Choudhary, Deepa Malla, Farukhzad Hafizyar, Abdul Subhan Talpur, Faryal Fatima, Marjan Khan. Prevalence of Thyroid Dysfunction in Patients With Hepatitis CCureus 2021;  doi: 10.7759/cureus.18289
23
Talari Praveen. Advances in Hepatology2021;  doi: 10.5772/intechopen.96734
24
A review on advancement towards hepatitis c virus genotyping and novel assays approach for determination of HCV GenotypesInternational Journal of Biosciences (IJB) 2019;  doi: 10.12692/ijb/15.6.420-440
25
Omkar Shinde, Pritee Chunarkar Patil, Gaber E. Eldesoky, Rupesh V. Chikhale. Integrated machine-learning methods for identification of Hepatitis C viral IRES sub-domain-IIa inhibitorsCanadian Journal of Chemistry 2026; 104(3) doi: 10.1139/cjc-2025-0046
26
Baris Otlu, Yusuf Yakupogullari, Elif Seren Tanriverdi. Revisiting Anti-HCV Seropositivity: Signal Intensity, Diagnostic Uncertainty, and the Limitations of Fixed Cut-OffsDiagnostics 2026; 16(16) doi: 10.3390/diagnostics16162665
27
Saade Abdalkareem Jasim, Najwa Shihab Ahmed, Adel A. Mousa, Ahmed A. Hmed, Ahmed R. Sofy. Phylogenetic tree of NS5A gene of hepatitis C virus from infected Iraqi patientsMaterials Today: Proceedings 2023; 80 doi: 10.1016/j.matpr.2021.07.409
28
Shunhua Guo, Meghan E Kapp, Diego M Beltran, Cesar Y Cardona, Dawn J Caster, Ronald R Reichel, Agnes B Fogo. Spectrum of Kidney Diseases in Patients With Hepatitis C Virus InfectionAmerican Journal of Clinical Pathology 2021; 156(3) doi: 10.1093/ajcp/aqaa238
29
Amina Gul, Nabeela Zahid, Jawad Ahmed, Fazli Zahir, Imtiaz Ali Khan, Ijaz Ali. Molecular characterization of Hepatitis C virus 3a in PeshawarBMC Infectious Diseases 2016; 16(1) doi: 10.1186/s12879-016-1488-0
30
Muttiah Barathan, Rosmawati Mohamed, Yean K. Yong, Meganathan Kannan, Jamuna Vadivelu, Alireza Saeidi, Marie Larsson, Esaki Muthu Shankar. Viral Persistence and Chronicity in Hepatitis C Virus Infection: Role of T-Cell Apoptosis, Senescence and ExhaustionCells 2018; 7(10) doi: 10.3390/cells7100165
31
Suh-Young Lee, Sun-Sin Kim, So-Hee Lee, Heung-Woo Park. Chronic viral hepatitis accelerates lung function decline in smokersClinical and Experimental Medicine 2022; 23(6) doi: 10.1007/s10238-022-00963-5
32
Chee-Hing Yang, Cheng-Hao Wu, Shih-Yen Lo, Ahai-Chang Lua, Yu-Ru Chan, Hui-Chun Li. Hepatitis C Virus Down-Regulates the Expression of Ribonucleotide Reductases to Promote Its ReplicationPathogens 2023; 12(7) doi: 10.3390/pathogens12070892
33
Xinran Liu, Derek Musser, Cheri Lee, Xiaorong Yang, Jamie Arnold, Craig Cameron, David Boehr. Nucleobase but not Sugar Fidelity is Maintained in the Sabin I RNA-Dependent RNA PolymeraseViruses 2015; 7(10) doi: 10.3390/v7102894
34
Duong Hoang Huy Le, Sitthichai Kanokudom, Ha Minh Nguyen, Ritthideach Yorsaeng, Sittisak Honsawek, Sompong Vongpunsawad, Yong Poovorawan. Hepatitis C Virus—Core Antigen: Implications in Diagnostic, Treatment Monitoring and Clinical OutcomesViruses 2024; 16(12) doi: 10.3390/v16121863
35
Mira Florea, Teodora Serban, George Razvan Tirpe, Alexandru Tirpe, Monica Lupsor-Platon. Noninvasive Assessment of Hepatitis C Virus Infected Patients Using Vibration-Controlled Transient ElastographyJournal of Clinical Medicine 2021; 10(12) doi: 10.3390/jcm10122575
36
O. V. Masalova, E. I. Lesnova, E. I. Samokhvalov, K. Yu. Permyakova, A. V. Ivanov, S. N. Kochetkov, A. A. Kushch. Low-molecular-weight regulators of biogenic polyamine metabolism affect cytokine production and expression of hepatitis С virus proteins in Huh7.5 human hepatocarcinoma cellsMolecular Biology 2017; 51(3) doi: 10.1134/S0026893317030128
37
Majid Mohsenizadeh, Taravat Bamdad, Motahareh Ghaziizadeh. Anti-hepatitis C virus antibody status and outcomes in serologic assays in blood donorsAsian Journal of Transfusion Science 2025; 19(2) doi: 10.4103/ajts.AJTS_156_21
38
Anahit Demirchyan, Antons Mozalevskis, Serine Sahakyan, Lusine Musheghyan, Lusine Aslanyan, Diana Muradyan, Narina Sargsyants, Gayane Ghukasyan, Varduhi Petrosyan. Seroprevalence of Hepatitis C Virus and Factors Associated with It in Armenia, 2021Viruses 2024; 16(9) doi: 10.3390/v16091446
39
Nourah Zoman Al-Zoman, Hadir Mohamed Maher, Amal Al-Subaie. Eco-friendly micellar electrokinetic capillary chromatographic method for the simultaneous determination of newly developed antiviral agents in pharmaceutical formulationsJournal of Liquid Chromatography & Related Technologies 2018; 41(17-18) doi: 10.1080/10826076.2018.1538884
40
Zeeshan Ahmed, Saman Zeeshan, Dinesh Mendhe, XinQi Dong. Human gene and disease associations for clinical‐genomics and precision medicine researchClinical and Translational Medicine 2020; 10(1) doi: 10.1002/ctm2.28
41
Hassan Khadempour-Arani, Ali Shojaeian, Ameneh Mehri-Ghahfarrokhi, HadiRaeisi Shahraki, Abbas Karimi, Alireza Dehghan, GholamReza Mobini. Identifying genotype profile of chronic hepatitis C infection in Southwest IranJournal of Research in Medical Sciences 2020; 25(1) doi: 10.4103/jrms.JRMS_524_19
42
Maliha Naseer, Harleen Chela, Alhareth AlJuboori. Viral Hepatitis: Chronic Hepatitis C2019;  doi: 10.1007/978-3-030-03757-4_2
43
Vivek Chavda, Kelsee K. Zajac, Jenna Lynn Gunn, Pankti Balar, Avinash Khadela, Dixa Vaghela, Shruti Soni, Charles R. Ashby, Amit K. Tiwari. Ethnic differences in hepatocellular carcinoma prevalence and therapeutic outcomesCancer Reports 2023; 6(S1) doi: 10.1002/cnr2.1821
44
Ahmad Shakeri, Natalia Konstantelos, Cherry Chu, Tony Antoniou, Jordan Feld, Katie J. Suda, Mina Tadrous. Global Utilization Trends of Direct Acting Antivirals (DAAs) during the COVID-19 Pandemic: A Time Series AnalysisViruses 2021; 13(7) doi: 10.3390/v13071314
45
Payuda Hansoongnern, Pornpitra Pratedrat, Pornjarim Nilyanimit, Rujipat Wasitthankasem, Nawarat Posuwan, Nasamon Wanlapakorn, Kanchanok Kodchakorn, Prachya Kongtawelert, Napaporn Pimsing, Yong Poovorawan, Maemu Petronella Gededzha. An amino acid substitution in HCV core antigen limits its use as a reliable measure of HCV infection compared with HCV RNAPLOS ONE 2023; 18(6) doi: 10.1371/journal.pone.0287694
46
Bryan R. Cobb, Alexandra Valsamakis, Randall T. Hayden, Donna M. Wolk, Karen C. Carroll, Yi-Wei Tang. Chronic Hepatitis B, C, and DMicrobiology Spectrum 2016; 4(4) doi: 10.1128/microbiolspec.DMIH2-0025-2015
47
Mohammad Nabil Abo-Zeid, Cheryl Walter, Katie Kitchman, Kirstine Eastick, Lynsey Corless, John Greenman. Disposable and sensitive electrochemical magneto-immunosensor for point-of-care HCV diagnostics: Targeting HCVcAg, the active viremia biomarker, in patient samplesBiosensors and Bioelectronics 2025; 272 doi: 10.1016/j.bios.2024.117104
48
Burak Ezer, Enes Kasapoğlu, Alperen Ceylan, Mehmet Özdemir. Genotype Distribution of HCV in Patients with Chronic Hepatitis C in a University HospitalViral Hepatitis Journal 2024; 30(3) doi: 10.4274/vhd.galenos.2024.2024-8-2
49
Mariantonietta Di Stefano, Mona H. Ismail, Thomas Leitner, Giuseppina Faleo, Marwan Jabr Alwazzeh, Jean Lutamyo Mbisa, Josè Ramon Fiore, Teresa Antonia Santantonio. A novel candidate hepatitis C virus genotype 4 subtype identified by next generation sequencing full-genome characterization in a patient from Saudi ArabiaFrontiers in Microbiology 2023; 14 doi: 10.3389/fmicb.2023.1285367
50
Hui-Chun Li, Chee-Hing Yang, Shih-Yen Lo. Hepatitis C Viral Replication ComplexViruses 2021; 13(3) doi: 10.3390/v13030520
51
H. Xiong, X. Rong, M. Wang, R. Xu, K. Huang, Q. Liao, J. Huang, J. Chen, C. Li, X. Tang, Z. Shan, M. Zhang, K. Nelson, Y. Fu. HBV/HCV co‐infection is associated with a high level of HCV spontaneous clearance among drug users and blood donors in ChinaJournal of Viral Hepatitis 2017; 24(4) doi: 10.1111/jvh.12644
52
Hamidreza Jahantigh, Nahid Ahmadi, Piero Lovreglio, Angela Stufano, Maryam Enayatkhani, Behzad Shahbazi, Khadijeh Ahmadi. Repurposing antiviral drugs against HTLV-1 protease by molecular docking and molecular dynamics simulationJournal of Biomolecular Structure and Dynamics 2023; 41(11) doi: 10.1080/07391102.2022.2078411
53
Michael Sandherr, Marcus Hentrich, Marie von Lilienfeld-Toal, Gero Massenkeil, Silke Neumann, Olaf Penack, Lena Biehl, Oliver A. Cornely. Antiviral prophylaxis in patients with solid tumours and haematological malignancies—update of the Guidelines of the Infectious Diseases Working Party (AGIHO) of the German Society for Hematology and Medical Oncology (DGHO)Annals of Hematology 2015; 94(9) doi: 10.1007/s00277-015-2447-3
54
Hui-Chun Li, Chee-Hing Yang, Shih-Yen Lo. Roles of microRNAs in Hepatitis C Virus Replication and PathogenesisViruses 2022; 14(8) doi: 10.3390/v14081776
55
Vikash Jaiswal, Song Peng Ang, Muhammad Hanif, Mayank Jha, Vikash Kumar, Abdelmonem Siddiq, Bhavyakumar Vachhani, Anupam Halder, Michelle Koifman, Herby Jeanty, Siddharath Soni, Madeeha Subhan Waleed, Tushar Kumar, Helen Huang, Dhrubajyoti Bandyopadhyay. Cardioprotective effect of antiviral therapy among hepatitis C infected patients: A meta-analysisIJC Heart & Vasculature 2023; 49 doi: 10.1016/j.ijcha.2023.101270
56
Karla Ribeiro Castro, Sthéfane Valle de Almeida, Ronaldo Censi Faria, Frank N. Crespilho. Advances in Bioelectrochemistry Volume 32022;  doi: 10.1007/978-3-030-97921-8_2
57
Fahimeh Ranjbar Kermani, Sedigheh Amini Kafi-Abad, Kamran Mousavi Hosseini, Mahtab Maghsoudlu, Zohre Sharifi, Shahram Samiee. Evaluation of the Performance Characteristics of an In-House One Step TaqMan Real Time-Polymerase Chain Reaction Assay for Detection and Quantification of Hepatitis C VirusJundishapur Journal of Microbiology 2017; 10(3) doi: 10.5812/jjm.42884
58
Zohre Eftekhari, Horieh Zohrabi, Akbar Oghalaie, Tahereh Ebrahimi, Fatemeh Sadat Shariati, Mahdi Behdani, Fatemeh Kazemi-Lomedasht. Advancements and challenges in mRNA and ribonucleoprotein-based therapies: From delivery systems to clinical applicationsMolecular Therapy - Nucleic Acids 2024; 35(3) doi: 10.1016/j.omtn.2024.102313
59
Abdulrahman Alduraywish, Mostafa Ragheb, Ibrahim Taher, Nageh Louis, Khaled Aldossari, Rania Kishk. Prevalence, risk factors and impact of occult HCV infection on liver morbidity among haemodialysis patients: hospital-based cross-sectional studyScandinavian Journal of Gastroenterology 2020; 55(8) doi: 10.1080/00365521.2020.1790649
60
Roberto Minutolo, Alessio Aghemo, Antonio Chirianni, Fabrizio Fabrizi, Loreto Gesualdo, Edoardo G. Giannini, Paolo Maggi, Vincenzo Montinaro, Ernesto Paoletti, Marcello Persico, Francesco Perticone, Salvatore Petta, Massimo Puoti, Giovanni Raimondo, Maria Rendina, Anna Linda Zignego. Management of hepatitis C virus infection in patients with chronic kidney disease: position statement of the joint committee of Italian association for the study of the liver (AISF), Italian society of internal medicine (SIMI), Italian society of infectious and tropical disease (SIMIT) and Italian society of nephrology (SIN)Internal and Emergency Medicine 2018; 13(8) doi: 10.1007/s11739-018-1940-9
61
Amira Souii, Aida Elargoubi, Catherine Fallecker, Maha Mastouri, Emmanuel Drouet. Hepatitis C Genotype Prevalence in Monastir Region, Tunisia: Correlation between 5′ Untranslated Region (5′UTR), Non-structural 5B (NS5B), and Core Sequences in HCV SubtypingCurrent Microbiology 2016; 73(3) doi: 10.1007/s00284-016-1064-2
62
Małgorzata Zdrodowska, Anna Kasperczuk, Agnieszka Dardzińska-Głębocka. Selected feature selection methods for classifying patients with Hepatitis CProcedia Computer Science 2023; 225 doi: 10.1016/j.procs.2023.10.366
63
Shreya Das, Arunima Mondal, Jayeeta Samanta, Santanu Chakraborty, Arunima Sengupta. Oxidative Stress and Toxicity in Reproductive Biology and MedicineAdvances in Experimental Medicine and Biology 2022; 1358 doi: 10.1007/978-3-030-89340-8_13
64
Hsin-Ying Ho, Wei-Sin Kao, Piyush Deval, Chia-Yen Dai, Yen-Hsu Chen, Ming-Lung Yu, Che-Hsin Lin, Ling-Shan Yu. Rapid and sensitive LAMP/CRISPR-powered diagnostics to detect different hepatitis C virus genotypes using an ITO-based EG-FET biosensing platformSensors and Actuators B: Chemical 2023; 394 doi: 10.1016/j.snb.2023.134278
65
Mojtaba Jafari, Parisa Mehdizadeh, Khosro Keshavarz, Ehsan Teymourzadeh, Mohammad Ali Abyazi, Seyed Moayed Alavian, Alijanpour Pouria. A cost-utility analysis of Glecaprevir/Pibrentasvir versus Sofosbuvir/Daclatasvir and Sofosbuvir/Velpatasvir for treatment of hepatitis C in IranCost Effectiveness and Resource Allocation 2025; 23(1) doi: 10.1186/s12962-025-00656-2
66
Fatimah Salem Alayidh, Alexander Woodman, Nawaf Yahya Zakary, Rehab Yusuf Al-Ansari, Sharjeel Chaudhry, Amal Omar Alsaadi, Khadijah Ahmad Alharbi, Batool Abdullah Alamri, Shahad Mousa Alhomud, Shahad Hassan Albather, Sarah Abdullah Bataweel, Nouf Ahmed Madkhali, Samira Jamaan Alzahrani, Zarmina Ehtesham. Direct-acting antiviral therapy in HCV patients: a retrospective study of the pre- and post-treatment impact in Saudi ArabiaBMC Infectious Diseases 2026; 26(1) doi: 10.1186/s12879-026-12648-5
67
Cecilia Trucchi, Andrea Orsi, Cristiano Alicino, Laura Sticchi, Giancarlo Icardi, Filippo Ansaldi. State of the Art, Unresolved Issues, and Future Research Directions in the Fight against Hepatitis C Virus: Perspectives for Screening, Diagnostics of Resistances, and ImmunizationJournal of Immunology Research 2016; 2016 doi: 10.1155/2016/1412840
68
Ya‐Juan Qin, Ruo‐cheng Sha, Yang‐Chun Feng, Yan‐Chun Huang. Comparison of double antigen sandwich and indirect enzyme‐linked immunosorbent assay for the diagnosis of hepatitis C virus antibodiesJournal of Clinical Laboratory Analysis 2020; 34(11) doi: 10.1002/jcla.23481
69
Alemu Gedefie, Abdurahaman Seid, Genet Molla Fenta, Mihret Tilahun, Agumas Shibabaw, Abdurrahman Ali. Hepatitis B and C virus infections and associated factors among HIV-positive and HIV-negative tuberculosis patients in public health facilities, Northeast Ethiopia: A comparative cross-sectional studySAGE Open Medicine 2023; 11 doi: 10.1177/20503121231166642
70
Andrea Angeletti, Chiara Cantarelli, Paolo Cravedi. HCV-Associated Nephropathies in the Era of Direct Acting Antiviral AgentsFrontiers in Medicine 2019; 6 doi: 10.3389/fmed.2019.00020
71
Navid Omidifar, Ahmad Sheykhfard, Nika Nikmanesh, Mansoureh Shokripour, Yousef Nikmanesh. Analysis of the Results of Hepatitis B and C Molecular Tests in Southern Iran from 2018 to 2022, the Possibility of Hepatitis C Genotype Change in the RegionAdvanced Biomedical Research 2025; 14(1) doi: 10.4103/abr.abr_148_24
72
Maria Cristina Morelli, Maria Rendina, Gaetano La Manna, Carlo Alessandria, Luisa Pasulo, Ilaria Lenci, Sherrie Bhoori, Piergiorgio Messa, Luigi Biancone, Loreto Gesualdo, Francesco Paolo Russo, Salvatore Petta, Patrizia Burra. Position paper on liver and kidney diseases from the Italian Association for the Study of Liver (AISF), in collaboration with the Italian Society of Nephrology (SIN)Digestive and Liver Disease 2021; 53 doi: 10.1016/j.dld.2021.03.035
73
Shreyasi Nath, Anwesha Ghosh, Raina Das, Sagnik Bakshi, Supradip Dutta, Priya Verma, Uttaran Bhattacharjee, Upasana Baskey, Sudipta Mondal, Kaushik Kumar Dey, Provash Chandra Sadhukhan. Differential Proteomic Profiling of Responders and Non-responders to Direct-Acting Antivirals Treatment in Chronic Hepatitis C Virus InfectionJournal of Proteome Research 2026;  doi: 10.1021/acs.jproteome.5c01003
74
Maryam Sadeghimehr, Barbara Bertisch, Christian Schaetti, Gilles Wandeler, Jean-Luc Richard, Claude Scheidegger, Olivia Keiser, Janne Estill. Modelling the impact of different testing strategies for HCV infection in SwitzerlandJournal of Virus Eradication 2019; 5(4) doi: 10.1016/S2055-6640(20)30036-4
75
Veronica Marcoux, Amanda Grant-Orser, Ciaran Scallan, Daniel-Costin Marinescu, Gillian C. Goobie, Stacey D. Lok, Alyson W. Wong, Archie La Rocque, Brett D. Edwards, Boyang Zheng, Charlene D. Fell, Deborah Assayag, Dina Fisher, Greg Peters, Helene Manganas, Jeannie Tom, Jolene H. Fisher, Julie Morisset, Kerri A. Johannson, Martin Kolb, Me-Linh Luong, Nathan Hambly, Rhea A. Varughese, Shane Shapera, Tianyan Chen, Christopher J. Ryerson. Infection screening before starting immunosuppression in interstitial lung disease: A Canadian Thoracic Society position statementCanadian Journal of Respiratory, Critical Care, and Sleep Medicine 2026; 10(2) doi: 10.1080/24745332.2026.2632675
76
Autumn Bagwell, Cody A. Chastain. Hepatitis C Treatment in HIV Coinfection: Approaches, Challenges, and Future OpportunitiesCurrent Treatment Options in Infectious Diseases 2016; 8(4) doi: 10.1007/s40506-016-0097-1
77
Historical and Epidemiological Analyses on the Impact of Infectious Disease on SocietyAdvances in Medical Diagnosis, Treatment, and Care 2022;  doi: 10.4018/978-1-7998-8689-1.ch005
78
Sonia Arca-Lafuente, Cristina Casanueva-Benítez, Celia Crespo-Bermejo, Violeta Lara-Aguilar, Luz Martín-Carbonero, Ignacio de los Santos, Ricardo Madrid, Verónica Briz. 903 Protein Saver cards: the best alternative for dried blood spot storage at room temperature for HCV RNAScientific Reports 2022; 12(1) doi: 10.1038/s41598-022-14375-8
79
Justin O. Ortiz, Jeffrey B. Brown, Ajay K. Varadhan, Charles Preuss. Infectious Diseases Drug Delivery Systems2023;  doi: 10.1007/978-3-031-20521-7_3
80
Chenxi Xu, Min Jin, Xiaobo Zhang. Virus Infection and Tumorigenesis2019;  doi: 10.1007/978-981-13-6198-2_6
81
Sakshi Kamboj, Akanksha Rajput, Amber Rastogi, Anamika Thakur, Manoj Kumar. Targeting non-structural proteins of Hepatitis C virus for predicting repurposed drugs using QSAR and machine learning approachesComputational and Structural Biotechnology Journal 2022; 20 doi: 10.1016/j.csbj.2022.06.060
82
Ana-Belén Blázquez, Juan-Carlos Saiz. Potential for Protein Kinase Pharmacological Regulation in Flaviviridae InfectionsInternational Journal of Molecular Sciences 2020; 21(24) doi: 10.3390/ijms21249524
83
Noha G. Bader El Din, Sally Farouk. Exploring the Impact of Different Inflammatory Cytokines on Hepatitis C Virus InfectionJournal of Interferon & Cytokine Research 2024; 44(6) doi: 10.1089/jir.2024.0003
84
Mahmoud El-Bendary, Sherief Abd-Elsalam, Tamer Elbaz, Wafaa El-Akel, Ahmed Cordie, Tamer Elhadidy, Hatem Elalfy, Khaled Farid, Mohamed Elegezy, Adel El-Badrawy, Mustafa Neamatallah, Mohamed Abd Elghafar, Marwa Salama, Mohamed AbdAllah, Mahmoud Essam, Mostafa El-Shazly, Gamal Esmat. RETRACTED ARTICLE: Efficacy of combined Sofosbuvir and Daclatasvir in the treatment of COVID-19 patients with pneumonia: a multicenter Egyptian studyExpert Review of Anti-infective Therapy 2022; 20(2) doi: 10.1080/14787210.2021.1950532
85
Roy L. Soiza, Chiara Scicluna, Sana Bilal. Biochemistry and Cell Biology of Ageing: Part IV, Clinical ScienceSubcellular Biochemistry 2023; 103 doi: 10.1007/978-3-031-26576-1_8
86
Yasemin Derya Gülseren, Ali Korhan Sığ, Muradiye Yarar. Optimizing Signal to Cut-off Values (S/Co) of Anti-HCV in Prediction of Viremia: A Retrospective Analysis with HCV-RNAJournal of Academic Research in Medicine 2023; 13(2) doi: 10.4274/jarem.galenos.2023.53254
87
KANNAN NARAYANAN, SUE ANN ZACHARIAH, SHEELA KURIAN V. ASPARTATE PLATELET RATIO INDEX AS A PREDICTOR OF SEVERITY OF FIBROSIS IN CHRONIC HEPATITS CAsian Journal of Pharmaceutical and Clinical Research 2023;  doi: 10.22159/ajpcr.2023.v16i4.47535
88
Clay Bolduc, Kenneth McCall, Kirsten Stickney, Alycia Gelinas, Eileen Levesque. Applicability of a new specialty pharmacy-reported measure describing completion of therapy for hepatitis CJournal of Managed Care & Specialty Pharmacy 2021; 27(2) doi: 10.18553/jmcp.2021.27.2.263
89
Saurav Sarkar, Prajna Gupta, Gouranga Nandi, Ranabir Sahu, Paramita Paul, Tarun Kumar Dua, Sreejan Manna. The Role of Nutraceuticals in Degenerative Diseases (Part 2)2026;  doi: 10.2174/9798898813369126010008
90
Palak K. Parikh, Nisha H. Parikh, Mahalakshmi B, Ketan M. Ranch, Sai H.S. Boddu, Jayachandra Babu R, Amit K. Tiwari. Developments in small molecule antiviral drugs against hepatitis B and C viruses: FDA approved therapies and new drugs in clinical trialsArabian Journal of Chemistry 2023; 16(8) doi: 10.1016/j.arabjc.2023.105013
91
Abuoma Cherry Ekpendu, Muhammad Sohaib Asghar, Rohin Patel, Martin Edward Avalos, Chad Kelly Brands, Pankajkumar Patel. Trends in Mortality Caused by Hepatitis C Virus in the United States Population: A Retrospective Cross-Sectional Study Using the CDC WONDER DatabaseDigestive Diseases and Sciences 2025; 70(9) doi: 10.1007/s10620-025-09161-1
92
Hiroki Sugimori, Maki Hirao, Ataru Igarashi, Hiroshi Yatsuhashi, Shunya Ikeda, Naohiko Masaki, Hiroshi Yotsuyanagi, Takeshi Yoda, Takeshi Odajima, Tomoyuki Takura, Tomohiro Hirao. Health state utilities of patients with hepatitis B and C and hepatitis-related conditions in JapanScientific Reports 2022; 12(1) doi: 10.1038/s41598-022-21470-3
93
Farahnaz Joukar, Sara Yeganeh, Narges Eslami, Fariborz Mansour‐Ghanaei. Hepatitis C Virus Infection in the PERSIAN Guilan Cohort Study Population: Intrafamilial Transmission Incidence and Response to SOVODAK‐Based TherapyHealth Science Reports 2026; 9(6) doi: 10.1002/hsr2.72619
94
Vigneswaran Narayanamurthy, Z. E. Jeroish, K. S. Bhuvaneshwari, Fahmi Samsuri. Hepatitis C virus (HCV) diagnosis via microfluidicsAnalytical Methods 2021; 13(6) doi: 10.1039/D0AY02045A
95
Mu-Hong Chen, Shih-Jen Tsai, Tzeng-Ji Chen. Protective Effect of Interferon-Based Antiviral Therapy on Risk of Bipolar Disorder in Patients with Hepatitis C Virus InfectionTaiwanese Journal of Psychiatry 2022; 36(4) doi: 10.4103/TPSY.TPSY_37_22
96
Hyun Jung Jo, Gyu Nam Park, Hye Ran Kim, Min Ju Kim, Kyung A Shin, Seung Bok Hong, Kyung Soo Chang. Differences in Hematological Characteristics, Including Cholesterol and Apolipoprotein B and E, between Hepatitis B Virus and Hepatitis C Virus Patients in KoreaJournal of Bacteriology and Virology 2016; 46(3) doi: 10.4167/jbv.2016.46.3.152
97
Adriana Gauna, Sandra Losada, María Lorenzo, Marilyan Toledo, Henry Bermúdez, Pierina D'Angelo, Doneyla Sánchez, Oscar Noya. Use of Synthetic Peptides and Multiple Antigen Blot Assay in the Immunodiagnosis of Hepatitis C Virus InfectionViral Immunology 2018; 31(8) doi: 10.1089/vim.2018.0023
98
Sources, purification, immobilization and industrial applications of microbial lipases: An overviewCritical Reviews in Food Science and Nutrition 2023; 63(24) doi: 10.1080/10408398.2022.2038076
99
Laura Guerrero, Alberto Paradela, Fernando J. Corrales. Targeted Proteomics for Monitoring One-Carbon Metabolism in Liver DiseasesMetabolites 2022; 12(9) doi: 10.3390/metabo12090779
100
Wim Schuermans, Hans Orlent, Isabelle Desombere, Patrick Descheemaeker, Hans Van Vlierberghe, Anja Geerts, Xavier Verhelst, Marijke Reynders, Elizaveta Padalko. Heads or Tails: Genotyping of Hepatitis C Virus Concerning the 2k/1b Circulating Recombinant FormInternational Journal of Molecular Sciences 2016; 17(9) doi: 10.3390/ijms17091384
101
Panagiotis Sarantis, Eleni-Myrto Trifylli, Evangelos Koustas, Kostas A. Papavassiliou, Michalis V. Karamouzis, Athanasios G. Papavassiliou. Immune Microenvironment and Immunotherapeutic Management in Virus-Associated Digestive System TumorsInternational Journal of Molecular Sciences 2022; 23(21) doi: 10.3390/ijms232113612
102
Davide Frumento, Ștefan Țălu. Interaction Between Human Microbiota, Immune System, and Hepatitis C Virus Infection: A Narrative ReviewApplied Sciences 2025; 15(6) doi: 10.3390/app15063157
103
Guolin Chen, Wei Zhang, Yiran Ben. Identification of Key Regulators of Hepatitis C Virus-Induced Hepatocellular Carcinoma by Integrating Whole-Genome and Transcriptome Sequencing DataFrontiers in Genetics 2021; 12 doi: 10.3389/fgene.2021.741608
104
Ivan Gentile, Alberto Enrico Maraolo, Antonio Riccardo Buonomo, Emanuela Zappulo, Guglielmo Borgia. The discovery of sofosbuvir: a revolution for therapy of chronic hepatitis CExpert Opinion on Drug Discovery 2015; 10(12) doi: 10.1517/17460441.2015.1094051
105
Ayat Gamal‐AbdelNaser, Waleed S. Mohammed, Mahmoud ElHefnawi, Mohamed AbdAllah, Aisha Elsharkawy, Fat'heya M. Zahran. The oral microbiome of treated and untreated chronic HCV infection: A preliminary studyOral Diseases 2023; 29(2) doi: 10.1111/odi.14007
106
Romina Mancinelli, Luigi Rosa, Antimo Cutone, Maria Stefania Lepanto, Antonio Franchitto, Paolo Onori, Eugenio Gaudio, Piera Valenti. Viral Hepatitis and Iron Dysregulation: Molecular Pathways and the Role of LactoferrinMolecules 2020; 25(8) doi: 10.3390/molecules25081997
107
Sangita K. Jindal, Richard G. Rawlins, Charles H. Muller, Erma Z. Drobnis. Guidelines for risk reduction when handling gametes from infectious patients seeking assisted reproductive technologiesReproductive BioMedicine Online 2016; 33(2) doi: 10.1016/j.rbmo.2016.04.015
108
Lantian Yao, Chang Liu, Yen-Peng Chiu, Jiahui Guan, Peilin Xie, Zhihao Zhao, Xingchen Liu, Yilin Guo, Yulan Liu, Yunlu Peng, Ying-Chih Chiang, Tzong-Yi Lee. Towards Accurate Identification of Anti-Hepatitis C Peptides Using Stack-AHCP2025 IEEE Conference on Computational Intelligence in Bioinformatics and Computational Biology (CIBCB) 2025;  doi: 10.1109/CIBCB66090.2025.11177129
109
Roberto Minutolo, Alessio Aghemo, Antonio Chirianni, Fabrizio Fabrizi, Loreto Gesualdo, Edoardo G. Giannini, Paolo Maggi, Vincenzo Montinaro, Ernesto Paoletti, Marcello Persico, Francesco Perticone, Salvatore Petta, Massimo Puoti, Giovanni Raimondo, Maria Rendina, Anna Linda Zignego. Management of hepatitis C virus infection in patients with chronic kidney disease: position statement of the joint committee of Italian association for the study of the liver (AISF), Italian society of internal medicine (SIMI), Italian society of infectious and tropical disease (SIMIT) and Italian society of nephrology (SIN)Journal of Nephrology 2018; 31(5) doi: 10.1007/s40620-018-0523-1
110
Marya Sadki, Karam Allali. Stochastic two-strain epidemic model with bilinear and non-monotonic incidence ratesThe European Physical Journal Plus 2023; 138(10) doi: 10.1140/epjp/s13360-023-04563-4
111
Melanie R. Walker, Auda A. Eltahla, Michael M. Mina, Hui Li, Andrew R. Lloyd, Rowena A. Bull. Envelope-Specific IgG3 and IgG1 Responses Are Associated with Clearance of Acute Hepatitis C Virus InfectionViruses 2020; 12(1) doi: 10.3390/v12010075
112
Sonia Arca-Lafuente, Paula Martínez-Román, Irene Mate-Cano, Ricardo Madrid, Verónica Briz. Nanotechnology: A reality for diagnosis of HCV infectious diseaseJournal of Infection 2020; 80(1) doi: 10.1016/j.jinf.2019.09.010
113
Sagnik Bakshi, Partha Chattopadhyay, Mahiuddin Ahammed, Raina Das, Moumita Majumdar, Supradip Dutta, Shreyasi Nath, Anwesha Ghosh, Uttaran Bhattacharjee, Upasana Baskey, Provash Chandra Sadhukhan. Efficacy of Different Combinations of Direct-Acting Antivirals Against Different Hepatitis C Virus-Infected Population Groups: An Experience in Tertiary Care Hospitals in West Bengal, IndiaViruses 2025; 17(2) doi: 10.3390/v17020269
114
Chirag V. Kapadia. Biomedical Science and Clinical Foundations2025;  doi: 10.1007/978-3-031-98353-5_17
115
Roberto Minutolo, Alessio Aghemo, Antonio Chirianni, Fabrizio Fabrizi, Loreto Gesualdo, Edoardo G. Giannini, Paolo Maggi, Vincenzo Montinaro, Ernesto Paoletti, Marcello Persico, Francesco Perticone, Salvatore Petta, Massimo Puoti, Giovanni Raimondo, Maria Rendina, Anna Linda Zignego. Management of hepatitis C virus infection in patients with chronic kidney disease: position statement of the joint committee of Italian association for the study of the liver (AISF), Italian society of internal medicine (SIMI), Italian society of infectious and tropical disease (SIMIT) and Italian society of nephrology (SIN)Infection 2019; 47(1) doi: 10.1007/s15010-018-1209-2
116
Sustained virological response in HCV patients receiving antiviral treatment at a teaching centre of northern IndiaJournal of Family Medicine and Primary Care 2025; 14(3) doi: 10.4103/jfmpc.jfmpc_1379_24
117
Vandana Sharma, Mahima Mahima, Sanjay Mankotia. Evaluation of Truenat results for viral hepatitisJournal of Laboratory Physicians 2026; 0 doi: 10.25259/JLP_47_2026
118
Madalina Gabriela Barbu, Carmen Elena Condrat, Dana Claudia Thompson, Oana Larisa Bugnar, Dragos Cretoiu, Oana Daniela Toader, Nicolae Suciu, Silviu Cristian Voinea. MicroRNA Involvement in Signaling Pathways During Viral InfectionFrontiers in Cell and Developmental Biology 2020; 8 doi: 10.3389/fcell.2020.00143
119
M. Haroon Hamed, Peter Natesan Pushparaj, Shafiqur Rehman, Saleh Al-Karim, Salem Bazarah, Ishtiaq Qadri. Deciphering the Significance of Plasma Chemokines as Prognostic Biomarkers in Pegylated IFN-Α-2a /Ribavirin-Treated Chronic Hepatitis C Genotype 4 PatientsInfectious Disorders - Drug Targets 2022; 22(5) doi: 10.2174/1871526522666220303142837
120
Yuan Hu. Advanced Techniques in Diagnostic Microbiology2018;  doi: 10.1007/978-3-319-95111-9_2
121
RadwaM Ismail, AmiraR Elansary, OlaM Ezzatt, MohamedG Hamed, Yasmine Gamil. Hepatitis C associated oral lesions: A hospital-based retrospective case control study in EgyptJournal of International Oral Health 2023; 15(1) doi: 10.4103/jioh.jioh_160_22
122
Gusnia Meilin Gholam, Mustika Luthfia, Iman Akhyar Firdausy. Molecular Docking: Bioactive Compounds in Indramayu Mango (Mangifera indica L.) Peel Waste as NS5B Hepatitis C Virus (HCV) InhibitorJURNAL FARMASI DAN ILMU KEFARMASIAN INDONESIA 2023; 10(1) doi: 10.20473/jfiki.v10i12023.1-10
123
Shahd Hamran, Amani A. Al-Rajhi, Kawthar Jasim, Majed A. Al-Theyab, Mohamed Elahtam, Mooza K. Al-Hail, Wadha Al-Fahaidi, Yaman A. Khamis, Yara Dweidri, Abdel-Naser Elzouki, Tawanda Chivese. Efficacy and Safety of Adding Ribavirin to Sofosbuvir-Based Direct-Acting Antivirals (DAAs) in Re-Treating Non-Genotype 1 Hepatitis C—A Systematic Review and Meta-AnalysisDiseases 2025; 13(5) doi: 10.3390/diseases13050138
124
Ehsan F Hussein, Aamal Ghazi Mahdi Al-Saadi, Aalaa Fahim Abbas. Study of the Complement Components and C-Reactive Proteins in Hepatitis Type C PatientsJournal of Physics: Conference Series 2019; 1294(6) doi: 10.1088/1742-6596/1294/6/062025
125
Jennifer Nguyen-Lee, Christine T. Nguyen-Buckley, Ani Bagdasarjana. Pharmacology and Physiology for Anesthesia2019;  doi: 10.1016/B978-0-323-48110-6.00032-6
126
Jiao Li, Yuanyuan Hu, Xiaomeng Hao, Jiali Tan, Fang Li, Xinran Qiao, Shuzhen Chen, Chunling Xiao, Minghua Chen, Zonggen Peng, Maoluo Gan. Raistrickindole A, an Anti-HCV Oxazinoindole Alkaloid from Penicillium raistrickii IMB17-034Journal of Natural Products 2019; 82(5) doi: 10.1021/acs.jnatprod.9b00259
127
Favian Su, Charles J. Cogan, Ilya Bendich, Ning Zhang, Mary A. Whooley, Alfred C. Kuo. Hepatitis C infection and complication rates after total shoulder arthroplasty in United States veteransJSES International 2021; 5(4) doi: 10.1016/j.jseint.2021.02.009
128
Sunil Thomas, Ann Abraham. Vaccine DesignMethods in Molecular Biology 2022; 2412 doi: 10.1007/978-1-0716-1892-9_2
129
Parisa Ebrahimzadeh, Mohammadreza Haghshenas, Farhang Babamahmoodi. The Prevalence of Hepatitis C Virus Genotypes in Mazandaran Province, IranJundishapur Journal of Microbiology 2017; (In press) doi: 10.5812/jjm.40750
130
Roberto Minutolo, Alessio Aghemo, Antonio Chirianni, Fabrizio Fabrizi, Loreto Gesualdo, Edoardo G. Giannini, Paolo Maggi, Vincenzo Montinaro, Ernesto Paoletti, Marcello Persico, Francesco Perticone, Salvatore Petta, Massimo Puoti, Giovanni Raimondo, Maria Rendina, Anna Linda Zignego. Management of hepatitis C virus infection in patients with chronic kidney disease: position statement of the joint committee of Italian association for the study of the liver (AISF), Italian society of internal medicine (SIMI), Italian society of infectious and tropical disease (SIMIT) and Italian society of nephrology (SIN)Digestive and Liver Disease 2018; 50(11) doi: 10.1016/j.dld.2018.08.022
131
Sudip Nepal, Erik D. Holmstrom, J.-H. James Ou. Single-molecule-binding studies of antivirals targeting the hepatitis C virus core proteinJournal of Virology 2023; 97(10) doi: 10.1128/jvi.00892-23
132
Bryan R. Cobb, Alexandra Valsamakis. Diagnostic Microbiology of the Immunocompromised Host2016;  doi: 10.1128/9781555819040.ch3
133
Zahra Hasanshahi, Ava Hashempour, Farzane Ghasabi, Javad Moayedi, Zahra Musavi, Behzad Dehghani, Heidar Sharafi, Hassan Joulaei. First report on molecular docking analysis and drug resistance substitutions to approved HCV NS5A and NS5B inhibitors amongst Iranian patientsBMC Gastroenterology 2021; 21(1) doi: 10.1186/s12876-021-01988-y
134
Michal Ordak, Tadeusz Nasierowski, Elzbieta Muszynska, Magdalena Bujalska-Zadrozny. Psychoactive Substances Taken with Mephedrone and HCV InfectionJournal of Clinical Medicine 2021; 10(15) doi: 10.3390/jcm10153218
135
Isaac Thom Shawa. Hepatitis B and C2020;  doi: 10.5772/intechopen.82772
136
Sooram Banesh, Surajbhan Sevda. Bioreactor Design Concepts for Viral Vaccine Production2024;  doi: 10.1016/B978-0-443-15378-5.00016-4
137
Pavlina Dzekova-Vidimliski, Aleksandar Sikole. Hepatitis C Virus Infection in Maintenance Hemodialysis Patients: Recommendations for Diagnostics and TreatmentThe International Journal of Artificial Organs 2016; 39(12) doi: 10.5301/ijao.5000548
138
Hui-Chun Li, Chee-Hing Yang, Shih-Yen Lo. Cellular factors involved in the hepatitis C virus life cycleWorld Journal of Gastroenterology 2021; 27(28): 4555-4581 doi: 10.3748/wjg.v27.i28.4555
139
Ilya Bendich, Steven Takemoto, Joseph T. Patterson, Alexander Monto, Thomas C. Barber, Alfred C. Kuo. Preoperative Treatment of Hepatitis C Is Associated With Lower Prosthetic Joint Infection Rates in US VeteransThe Journal of Arthroplasty 2019; 34(7) doi: 10.1016/j.arth.2019.02.052
140
Davaalkham Dambadarjaa, Yerkyebulan Mukhtar, Enkh-Oyun Tsogzolbaatar, Ser-Od Khuyag, Angarmurun Dayan, Nandin-Erdene Oyunbileg, Oyu-Erdene Shagdarsuren, Gunchmaa Nyam, Yosikazu Nakamura, Masaharu Takahashi, Hiroaki Okamoto. Hepatitis B, C, and D Virus Infections and AFP Tumor Marker Prevalence Among the Elderly Population in Mongolia: A Nationwide SurveyJournal of Preventive Medicine and Public Health 2022; 55(3) doi: 10.3961/jpmph.21.573
141
Vandana Sharma, Mahima Mahima, Rahul Kaundal, Sanjay Mankotia, Dinesh Kumar. Secondary Analysis for Surveillance of Hepatitis C Virus Transmission from a Secondary-Level Hospital in Himachal Pradesh, India: A Brief ReportJournal of Gastrointestinal Infections 2025; 15(01/02) doi: 10.1055/s-0045-1811266
142
O. V. Masalova, E. I. Lesnova, K. Yu. Permyakova, E. I. Samokhvalov, A. V. Ivanov, S. N. Kochetkov, A. A. Kushch. Effect of Hepatitis C virus proteins on the production of proinflammatory and profibrotic cytokines in Huh7.5 human hepatoma cellsMolecular Biology 2016; 50(3) doi: 10.1134/S0026893316020163
143
Shrikant Dashrath Warkad, Keum-Soo Song, Dilipkumar Pal, Satish Balasaheb Nimse. Developments in the HCV Screening Technologies Based on the Detection of Antigens and AntibodiesSensors 2019; 19(19) doi: 10.3390/s19194257
144
Christopher M. Goodwin, Shihao Xu, Joshua Munger. Stealing the Keys to the Kitchen: Viral Manipulation of the Host Cell Metabolic NetworkTrends in Microbiology 2015; 23(12) doi: 10.1016/j.tim.2015.08.007